What is NRXP's dilution risk score?

NRXP has a latest available DilutionScore record of 33/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for NRXP, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for NRXP?

DilutionWatch tracks 25 SEC filing types for NRXP including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect NRXP shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For NRXP, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for NRXP tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for NRXP. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

NRXP Dilution Risk Score: 33/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

50

💰 Cash Runway

25

📊 Float Risk

35

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $20M remaining capacity

🔔 Track NRXP — Get forecast alerts →

Market Data

Market Cap$160.13M

Shares Outstanding43.30M

Float30.45M

Cash$26.69M

Debt$11.98M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 42.8% shares (2026Q1 vs prior)

35 institutional holders · 7.62M shares

#1 B Group, Inc. 3.00M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 2.32M shares

#3 AdvisorShares Investments LLC 420.5K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.55M

Days to Cover7.6

% of Float21.5%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2025-12-31

8-K 8K EVENT 2026-03-24

4 INSIDER TRANSACTION 2026-02-17

3 FORM3 2026-02-17

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual NRXP Dilution Snapshot

NRx Pharmaceuticals, Inc. (NRXP) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $20.0M.
Stored outstanding warrants: 270,000.
Recent SEC activity tracked for NRXP: 8-K on 2026-03-24; 4 on 2026-02-17; 3 on 2026-02-17.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.